LongGame Ventures
Overview
LongGame Ventures is a venture capital firm that invests in longevity biotech startups with the aim of radically increasing healthy human lifespan.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Metabolize | Oct 2026 | Seed | Co-investor |
| Syntax Bio | Jun 2026 | Series A | Co-investor |
| ImmuneBridge | Mar 2026 | Seed | Co-investor |
| Vincere Biosciences | Nov 2025 | Grant | Co-investor |
| RenewalBio | Nov 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is LongGame Ventures based?
LongGame Ventures is headquartered in London, England, United Kingdom.
When was LongGame Ventures founded?
LongGame Ventures was founded in 2024.
How many portfolio companies does LongGame Ventures have?
LongGame Ventures has 9 portfolio companies in Caplight's dataset.
What are some companies in LongGame Ventures's portfolio?
Recent investments visible on Caplight include Metabolize, Syntax Bio, ImmuneBridge, Vincere Biosciences, RenewalBio.
What was LongGame Ventures's most recent investment?
LongGame Ventures's most recent investment on Caplight was in Metabolize in 2026.
What sectors does LongGame Ventures focus on?
LongGame Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech.
What company stages does LongGame Ventures focus on?
LongGame Ventures typically invests at the Early stage.
What is LongGame Ventures's AUM?
LongGame Ventures's assets under management are estimated between $40.0M and $40.0M.